Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,020,000
Closed -$2.86M 114
2024
Q1
$2.86M Buy
1,020,000
+20,000
+2% +$62.3K 0.07% 77
2023
Q4
$1.93M Hold
1,000,000
0.06% 66
2023
Q3
$1.53M Hold
1,000,000
0.07% 73
2023
Q2
$1.48M Hold
1,000,000
0.05% 85
2023
Q1
$1.45M Hold
1,000,000
0.09% 85
2022
Q4
$1.32M Hold
1,000,000
0.07% 100
2022
Q3
$1.28M Hold
1,000,000
0.05% 105
2022
Q2
$2.07M Hold
1,000,000
0.11% 94
2022
Q1
$3.5M Hold
1,000,000
0.15% 96
2021
Q4
$8.07M Hold
1,000,000
0.22% 77
2021
Q3
$14.4M Hold
1,000,000
0.32% 66
2021
Q2
$13.6M Buy
1,000,000
+200,000
+25% +$2.78M 0.28% 76
2021
Q1
$14.4M Buy
+800,000
New +$18.2M 0.25% 80

Other funds holding ADAG

Artal Group's ADAG Position: Q2 2024 in Review

Artal Group sold out of Adagene (ADAG) in Q2 2024, closing a stake of 1,020,000 shares — an estimated $2.86M sold.

Artal Group first reported a position in ADAG in Q1 2021 and held it in 13 quarters. The position peaked at $14.4M in Q3 2021. 14 funds tracked by Wall St. Rank hold ADAG as of Q2 2024.

  • Artal Group reported no remaining Adagene position as of Q2 2024 after selling out during the quarter.
  • Artal Group sold 1,020,000 Adagene shares in Q2 2024, an estimated $2.86M.
  • Artal Group first reported a position in Adagene in Q1 2021 and held it in 13 quarters.
  • Artal Group's Adagene position peaked at $14.4M in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Adagene as of Q2 2024.

Based on Artal Group's 13F filing for Q2 2024, filed 14 Aug 2024.